Results 1 to 10 of about 314,408 (190)
Pancreatic exocrine insufficiency in diabetes mellitus [PDF]
Сахарный диабет, 2023 Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes and affect not only the quality, but also life expectancy. At the same time, the diagnosis and
M. V. Shestakova +10 more
doaj +2 more sources
Congenital etiologies of exocrine pancreatic insufficiency
Frontiers in Pediatrics, 2022 Congenital exocrine pancreatic insufficiency is a rare condition. In a vast majority of patients, exocrine dysfunction occurs as part of a multisystemic disease, the most prevalent being cystic fibrosis and Shwachman-Bodian-Diamond syndrome.
Isabelle Scheers, Silvia Berardis
doaj +2 more sources
A Rare Case of Exocrine Pancreatic Insufficiency [PDF]
European Journal of Case Reports in Internal Medicine, 2021 Lipomatous pseudohypertrophy (LPH) of the pancreas is an uncommon affection of exocrine pancreatic insufficiency. It is defined as substitution of the pancreatic exocrine gland by a large fat component.
Mohamed Labied +6 more
doaj +2 more sources
Nivolumab-Induced Exocrine Pancreatic Insufficiency
Case Reports in Oncology, 2021 Immunotherapy is increasingly gaining applicability for several malignancies. While the survival of several malignancies has dramatically improved, immune-related adverse events (irAEs) can occur and can cause severe damage to patients. Side effects such
Boudewijn Sweep +2 more
doaj +3 more sources
Secondary exocrine pancreatic insufficiency. Features of the choice of the enzyme
Медицинский совет, 2021 Exocrine pancreatic insufficiency is quite common in clinical practice of doctors of many specialties. Decrease in intraduodenal lipase levels below 5–10% of normal leads to pancreatic steatorrhea, weight loss and a potential decrease in quality of life.
I. G. Pakhomova
doaj +1 more source
Pharmaceutics, 2023 This review presents current updates of pancreatic enzyme replacement therapy in children with cystic fibrosis based on literature published in the last decade and some special considerations regarding pancreatic enzyme replacement therapy in the era of ...
Mirela-Elena Ritivoiu +7 more
doaj +1 more source
Frontiers in Gastroenterology, 2023 The galactose-α-1,3-galactose (α-gal) mammalian meat allergy, α-gal syndrome, often includes diarrhea, abdominal pain, and other gastrointestinal (GI) symptoms. Pancreatic exocrine insufficiency causes similar symptoms. The pancreatic replacement enzymes,
Nathan E. Richards +3 more
doaj +1 more source
Медицинский совет, 2021 Chronic pancreatitis is a multifactorial disease in which repeated episodes of inflammation of the pancreas contribute to the development of fibrous tissue, leading to chronic pain, as well as exocrine and endocrine insufficiency.
V. N. Drozdov +7 more
doaj +1 more source
BMC Gastroenterology, 2020 Background Pancreatic duct ligation in a minipig model leads to exocrine pancreatic insufficiency (EPI). This allows the study of digestive processes and pancreatic enzyme replacement therapies.
Andreas Minh Luu +13 more
doaj +1 more source
Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines
BMJ Open Gastroenterology, 2021 Introduction Pancreatic exocrine insufficiency is a finding in many conditions, predominantly affecting those with chronic pancreatitis, pancreatic cancer and acute necrotising pancreatitis.
John S Leeds +6 more
doaj +1 more source